Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 16 | $14,292,723 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 30 May 2024 18:21 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 28 May 2024 | Sale | 300,000 | 34.3 | 10,290,000 | I |
| 02 Mar 2023 16:17 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 01 Mar 2023 | Sale | 400 | 24.7075 | 9,883 | I |
| 02 Mar 2023 16:17 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 01 Mar 2023 | Sale | 39,600 | 24.2007 | 958,348 | I |
| 02 Feb 2023 19:26 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 02 Feb 2023 | Sale | 1,130 | 25.8947 | 29,261 | I |
| 02 Feb 2023 19:26 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 02 Feb 2023 | Sale | 10,120 | 25.4045 | 257,094 | I |
| 02 Feb 2023 19:26 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 01 Feb 2023 | Sale | 693 | 25.6567 | 17,780 | I |
| 02 Feb 2023 19:26 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 01 Feb 2023 | Sale | 14,608 | 25.0798 | 366,366 | I |
| 02 Feb 2023 19:26 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 01 Feb 2023 | Sale | 13,449 | 24.2925 | 326,710 | I |
| 04 Jan 2023 17:53 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 04 Jan 2023 | Sale | 3,003 | 23.9903 | 72,043 | I |
| 04 Jan 2023 17:53 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 04 Jan 2023 | Sale | 4,102 | 23.1072 | 94,786 | I |
| 04 Jan 2023 17:53 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 03 Jan 2023 | Sale | 2,084 | 25.0927 | 52,293 | I |
| 04 Jan 2023 17:53 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 03 Jan 2023 | Sale | 8,598 | 24.3575 | 209,426 | I |
| 04 Jan 2023 17:53 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 03 Jan 2023 | Sale | 22,213 | 23.412 | 520,051 | I |
| 07 Dec 2022 16:30 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 06 Dec 2022 | Sale | 1,392 | 28.4608 | 39,617 | I |
| 07 Dec 2022 16:30 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 06 Dec 2022 | Sale | 17,681 | 27.5716 | 487,493 | I |
| 07 Dec 2022 16:30 | INBX | Inhibrx Inc | ECKELMAN BRENDAN P. | Chief Scientific Officer | 06 Dec 2022 | Sale | 20,927 | 26.8348 | 561,572 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)